Redox imbalance in Crohn's disease patients is modulated by Azathioprine

References

• Boyapati R, Satsangi J, Ho GT. Pathogenesis of Crohn's disease. F1000Prime Rep. 2015;7:44.
   PubMedGoogle Scholar
• Wójcik B, Loga K, Włodarczyk M, et al. Extraintestinal manifestations of Crohn's disease. Prz Gastroenterol. 2016;11(3):218–221.
   PubMed Web of Science ®Google Scholar
• Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769–2778.
   PubMed Web of Science ®Google Scholar
• Jess T, Riis L, Vind I, et al. Changes in clinical characteristics, course, and prognosis of inflammatory bowel disease during the last 5 decades: a population-based study from Copenhagen, Denmark. Inflamm Bowel Dis. 2007;13(4):481–489.
   PubMed Web of Science ®Google Scholar
• Younis N, Zarif R, Mahfouz R. Inflammatory bowel disease: between genetics and microbiota. Mol Biol Rep. 2020;47(4):3053–3063.
   PubMed Web of Science ®Google Scholar
• Deretic V. Links between autophagy, innate immunity, inflammation and Crohn's disease. Dig Dis. 2009;27(3):246–251.
   PubMed Web of Science ®Google Scholar
• Lee JY, Wasinger VC, Yau YY, et al. Molecular pathophysiology of epithelial barrier dysfunction in inflammatory bowel diseases. Proteomes. 2018;6(2):17.
   Web of Science ®Google Scholar
• Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474(7351):298–306.
   PubMed Web of Science ®Google Scholar
• Pascal V, Pozuelo M, Borruel N, et al. A microbial signature for Crohn's disease. Gut. 2017;66(5):813–822.
   PubMed Web of Science ®Google Scholar
• Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol. 1993;94(1):174–181.
   PubMed Web of Science ®Google Scholar
• Fais S, Capobianchi MR, Pallone F, et al. Spontaneous release of interferon gamma by intestinal lamina propria lymphocytes in Crohn's disease. kinetics of in vitro response to interferon gamma inducers. Gut. 1991;32(4):403–407.
   PubMed Web of Science ®Google Scholar
• Hernández-Espinosa DR, Massieu L, Montiel T, et al. Role of NADPH oxidase-2 in the progression of the inflammatory response secondary to striatum excitotoxic damage. J Neuroinflammation. 2019;16(1):91.
   PubMedGoogle Scholar
• Vignais PV. The superoxide-generating NADPH oxidase: structural aspects and activation mechanism. Cell Mol Life Sci. 2002;59(9):1428–1459.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bazhin AV, Werner J, et al. Reactive oxygen species in the immune system. Int Rev Immunol. 2013;32(3):249–270.
   PubMed Web of Science ®Google Scholar
• De Rasmo D, Ferretta A, Russo S, et al. PBMC of multiple sclerosis patients show deregulation of OPA1 processing associated with increased ROS and PHB2 protein levels. Biomedicines. 2020;8(4):85.
   PubMed Web of Science ®Google Scholar
• Denson LA, Jurickova I, Karns R, et al. Clinical and genomic correlates of neutrophil Reactive oxygen species production in pediatric patients With Crohn's disease. Gastroenterology. 2018;154(8):2097–2110.
   PubMed Web of Science ®Google Scholar
• Birben E, Sahiner UM, Sackesen C, et al. Oxidative stress and antioxidant defense. World Allergy Organ J. 2012;5(1):9–19.
   PubMedGoogle Scholar
• Dong J, Sulik KK, Chen SY. Nrf2-mediated transcriptional induction of antioxidant response in mouse embryos exposed to ethanol in vivo: implications for the prevention of fetal alcohol spectrum disorders. Antioxid Redox Signal. 2008;10(12):2023–2033.
   PubMed Web of Science ®Google Scholar
• Johnson DA, Amirahmadi S, Ward C, et al. The absence of the pro-antioxidant transcription factor Nrf2 exacerbates experimental autoimmune encephalomyelitis. Toxicol Sci Official J Soc Toxicol. 2010;114(2):237–246.
   PubMed Web of Science ®Google Scholar
• Suzuki T, Murakami S, Biswal SS, et al. Systemic activation of NRF2 alleviates lethal autoimmune inflammation in scurfy mice. Mol Cell Biol. 2017;37(15):e00063-17.
   Web of Science ®Google Scholar
• Sireesh D, Dhamodharan U, Ezhilarasi K, et al. Association of NF-E2 related factor 2 (Nrf2) and inflammatory cytokines in recent onset type 2 diabetes mellitus. Sci Rep. 2018;8(1):5126.
   PubMedGoogle Scholar
• Pryor RJ, Wittwer CT. Real-time polymerase chain reaction and melting curve analysis. Meth Mol Biol. 2006;336:19–32.
   PubMedGoogle Scholar
• Lobo V, Patil A, Phatak A, et al. Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev. 2010;4(8):118–126.
   PubMedGoogle Scholar
• Mittal M, Siddiqui MR, Tran K, et al. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. 2014;20(7):1126–1167.
   PubMed Web of Science ®Google Scholar
• Luceri C, Bigagli E, Agostiniani S, et al. Analysis of oxidative stress-related markers in Crohn's disease patients at surgery and correlations with clinical findings. Antioxidants. 2019;8(9):378.
   Web of Science ®Google Scholar
• Bourgonje AR, von Martels JZH, Bulthuis MLC, et al. Crohn's disease in clinical remission Is marked by Systemic oxidative stress. Front Physiol. 2019;10:499.
   PubMed Web of Science ®Google Scholar
• Alzoghaibi MA. Concepts of oxidative stress and antioxidant defense in Crohn's disease. World J Gastroenterol. 2013;19(39):6540–6547.
   PubMed Web of Science ®Google Scholar
• Di Dalmazi G, Hirshberg J, Lyle D, et al. Reactive oxygen species in organ-specific autoimmunity. Auto Immun Highlights. 2016;7(1):11.
   PubMed Web of Science ®Google Scholar
• Bao S, Carr ED, Xu YH, et al. Gp91(phox) contributes to the development of experimental inflammatory bowel disease. Immunol Cell Biol. 2011;89(8):853–860.
   PubMed Web of Science ®Google Scholar
• Regmi SC, Park SY, Ku SK, et al. Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species. Free Radic Biol Med. 2014;69:377–389.
   PubMed Web of Science ®Google Scholar
• Guan G, Lan S. Implications of antioxidant systems in inflammatory bowel disease. Biomed Res Int. 2018;2018:1290179.
   PubMed Web of Science ®Google Scholar
• Wang Y, Branicky R, Noë A, et al. Superoxide dismutases: dual roles in controlling ROS damage and regulating ROS signaling. J Cell Biol. 2018;217(6):1915–1928.
   PubMed Web of Science ®Google Scholar
• Fukui M, Zhu BT. Mitochondrial superoxide dismutase SOD2, but not cytosolic SOD1, plays a critical role in protection against glutamate-induced oxidative stress and cell death in HT22 neuronal cells. Free Radic Biol Med. 2010;48(6):821–830.
   PubMed Web of Science ®Google Scholar
• Dincer Y, Erzin Y, Himmetoglu S, et al. Oxidative DNA damage and antioxidant activity in patients with inflammatory bowel disease. Dig Dis Sci. 2007;52(7):1636–1641.
   PubMed Web of Science ®Google Scholar
• Iborra M, Moret I, Rausell F, et al. Role of oxidative stress and antioxidant enzymes in Crohn's disease. Biochem Soc Trans. 2011;39(4):1102–1106.
   PubMed Web of Science ®Google Scholar
• Verspaget HW, Peña AS, Weterman IT, et al. Diminished neutrophil function in Crohn's disease and ulcerative colitis identified by decreased oxidative metabolism and low superoxide dismutase content. Gut. 1988;29(2):223–228.
   PubMed Web of Science ®Google Scholar
• Nazli A, Yang P-C, Jury J, et al. Epithelia under metabolic stress perceive commensal bacteria as a threat. Am J Pathol. 2004;164(3):947–957.
   PubMed Web of Science ®Google Scholar
• Söderholm JD, Yang PC, Ceponis P, et al. Chronic stress induces mast cell-dependent bacterial adherence and initiates mucosal inflammation in rat intestine. Gastroenterology. 2002;123(4):1099–1108.
   PubMed Web of Science ®Google Scholar
• Rodenburg W, Keijer J, Kramer E, et al. Impaired barrier function by dietary fructo-oligosaccharides (FOS) in rats is accompanied by increased colonic mitochondrial gene expression. BMC Genomics. 2008;9:144.
   PubMed Web of Science ®Google Scholar
• Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol. 2015;3:62,
   PubMed Web of Science ®Google Scholar
• Mitsuishi Y, Motohashi H, Yamamoto M. The Keap1–Nrf2 system in cancers: stress response and anabolic metabolism. Front Oncol. 2012;2:200.
   PubMedGoogle Scholar
• Itoh K, Ye P, Matsumiya T, et al. Emerging functional cross-talk between the Keap1-Nrf2 system and mitochondria. J Clin Biochem Nutr. 2015;56(2):91–97.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Kensler TW, Motohashi H. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169–1203.
   PubMed Web of Science ®Google Scholar
• Kasai S, Shimizu S, Tatara Y, et al. Regulation of Nrf2 by mitochondrial Reactive oxygen species in physiology and pathology. Biomoleules. 2020;10(2):320.
   PubMed Web of Science ®Google Scholar
• Wu J, Gao Y, Yang C, et al. Low-dose azathioprine is effective in maintaining remission among Chinese patients with Crohn's disease. J Transl Med. 2013;11:235.
   PubMed Web of Science ®Google Scholar
• Timmer A, Patton PH, Chande N, et al. Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitis. Cochrane Database Syst Rev. 2016;2016(5):Cd000478.
   PubMed Web of Science ®Google Scholar
• Lee SH, Kwon JE, Cho ML. Immunological pathogenesis of inflammatory bowel disease. Intest Res. 2018;16(1):26–42.
   PubMed Web of Science ®Google Scholar
• Gerstgrasser A, Melhem H, Leonardi I, et al. Cell-specific activation of the Nrf2 antioxidant pathway increases mucosal inflammation in acute but Not in chronic colitis. J Crohns Colitis. 2017;11(4):485–499.
   PubMed Web of Science ®Google Scholar
• Abais JM, Xia M, Zhang Y, et al. Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector? Antioxid Redox Signal. 2015;22(13):1111–1129.
   PubMed Web of Science ®Google Scholar
• Kalra S, Knatko EV, Zhang Y, et al. Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): implications for protection against UV radiation during thiopurine therapy. Cancer Prevent Res. 2012;5(7):973–981.
   PubMed Web of Science ®Google Scholar